Severe pulmonary adverse effects in lymphoma patients treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus rituximab.
Rituximab (B-cell depleting antibody) associated lung injury (RALI): a pediatric case and systematic review of the literature.
Severe interstitial pneumonitis following rituximab and bleomycin-containing combination chemotherapy.
Acute respiratory distress syndrome during the third infusion of rituximab in a patient with follicular lymphoma.
